N/A
N=53
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Spinal Cord Injury
Bottom Line
View on ClinicalTrials.gov: NCT01183546 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcome: Primary: Transfer Performance (TAI Scores Part 1) — 6.31; 9.92 units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Transfer Performance (TAI Scores Part 1) |
6.31; 9.92 | — |
| SECONDARY Shoulder Peak Resultant Moment |
0.97; 0.62 | — |
Summary
The purpose of this research study is to further develop and refine the Transfer Assessment Instrument (TAI). The TAI is a clinical tool to be used by therapists to evaluate transfer techniques and performance.
Eligibility Criteria
Inclusion Criteria
For preliminary phase (control subjects)
- 18 years old or over
- Ability to do a seated push up (from a seated position, elevate torso and lift buttocks off of the seat using the upper limbs)
For final phase (case subjects)
- 18 years old or over
- C4 level or below spinal cord injury
- Ability to perform an independent transfer (without assistive device or human assistance)
- Manual wheelchair user For preliminary phase (control subjects)
(1) No significant upper extremity pain or injury that would inhibit the ability to perform transfers or weight bear on the upper extremities.
Exclusion Criteria
For final phase (case subjects)
- No significant upper extremity pain or injury that would inhibit the ability to perform transfers or weight bear on the upper extremities.
- A history of cardiopulmonary (heart/lung condition) that may be exacerbated.
- Active pressure sores, or a history of pressures sores that may be exacerbated.
- Functional motor control in the lower extremities.
Data sourced from ClinicalTrials.gov (NCT01183546). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.